The Supreme Court announced last week that it will hear Monsanto’s claim that it should be shielded from tens of thousands of lawsuits over Roundup because the Environmental Protection Agency (EPA) has not required a warning label that the weedkiller may cause cancer. This court decision could effectively curtail one of the largest waves of tort litigation in American history, with far-reaching implications for consumers, farmers, and the agricultural industry.
The Issue the Supreme Court Must Rule On
The Supreme Court will examine whether federal law preempts state-level failure-to-warn claims against Roundup–maker Monsanto, now owned by Bayer. At the heart of this legal battle is the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), which governs pesticide regulation in the United States. Bayer argues that since the EPA has repeatedly approved Roundup’s label without requiring cancer warnings, the company should be protected from state lawsuits alleging inadequate warnings.
The Roundup cancer lawsuit that prompted this Supreme Court review involves John Durnell, a Missouri resident who allegedly developed non-Hodgkin’s lymphoma after years of using Roundup in community gardens. A jury awarded him $1.25 million in damages after finding Monsanto liable for failing to warn about potential cancer risks.
Scientific Controversy Surrounding Glyphosate Exposure
While the Supreme Court won’t directly address the issue of whether Roundup weedkiller causes cancer, the scientific debate forms the backdrop of this legal battle. Glyphosate, Roundup’s active ingredient, has been the subject of conflicting scientific assessments over the years.
In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans.” This determination sparked thousands of Roundup lawsuits against Monsanto. However, the EPA has consistently maintained that glyphosate does not pose a cancer risk when used according to label directions.
Adding to the controversy, a scientific journal recently retracted a widely cited paper that had declared glyphosate safe. The retraction came after emails revealed in litigation suggested Monsanto scientists had guided the research, raising questions about the independence of scientific evaluations used by regulatory agencies.
The Financial Stakes for Bayer
The financial implications of this Roundup lawsuit review are enormous. Bayer has already paid out more than $10 billion to settle approximately 100,000 Roundup claims and faces thousands more. A ruling in Bayer’s favor could potentially save the company billions by allowing it to dismiss many pending Roundup cancer lawsuits. It could also establish a precedent, making it more difficult to hold manufacturers accountable when federal agencies approve their products.
Beyond Roundup itself, the Supreme Court’s decision could reshape how courts handle conflicts between federal regulators and state consumer protection laws. If the Supreme Court sides with Bayer, it may narrow the ability of states to enforce their own warning requirements when federal agencies approve product labels. That shift would affect not only pesticides but also pharmaceuticals, household chemicals, and other regulated products, limiting the role of juries in weighing evidence that emerges after federal approval.
Legal scholars say the ruling could redefine where regulatory authority ends and corporate liability begins, changing how future injury claims are litigated across the country.
What Happens Next?
The Supreme Court will likely hear arguments in the Roundup lawsuit review in April and issue a ruling by late June. The court’s decision could either preserve the ability of individuals to seek compensation for alleged Roundup-related injuries, like cancer, or effectively end most pending litigation against Bayer.
Whatever the outcome, this review highlights the complex intersection of science, regulation, and law in addressing potential public health risks. As this landmark claim moves forward, it serves as a reminder of the importance of vigilance regarding product safety and the ongoing need for transparent, independent scientific assessment of chemicals widely used in our food system.
Roundup Lawsuit Information
Roundup Lawsuits, Leading Justice
Appeals Court Upholds Million-Dollar Verdict in Roundup Cancer Lawsuit, Leading Justice
Journal Retracts Key Study Claiming Roundup Doesn’t Cause Cancer, Leading Justice
Bayer To Pay More Than $10 Billion To Resolve Cancer Lawsuits Over Weedkiller Roundup, NPR
Supreme Court may block thousands of lawsuits over Roundup weed killer, LA Times

